Lymphatic EC response to VEGFC
From FANTOM5_SSTAR
Series: | IN_VITRO DIFFERENTIATION SERIES |
---|---|
Species: | Human (Homo sapiens) |
Genomic View: | Zenbu |
Expression table: | [{{{tet_config}}} FILE] |
Link to TET: | [{{{tet_file}}} TET] |
Sample providers : | Michael Detmar |
Germ layer: | {{{germ_layer}}} |
Primary cells or cell line: | {{{primary_cells}}} |
Time span: | {{{time_span}}} |
Number of time points: | {{{number_time_points}}} |
Overview |
---|
The lymphatic vasculature plays a critical role in the maintenance of tissue fluid balance, the uptake of dietary fats and the immune response. Lymphatic vessels are also actively involved in pathological conditions, in particular in promoting cancer metastasis to lymph nodes and in controlling chronic inflammatory diseases (1, 2, 3, 4). The growth of new lymphatic vessels from pre-existing vasculature is called lymphangiogenesis. The main pathway regulating lymphangiogenesis is VEGF-C signaling via its receptor VEGFR-3 on lymphatic endothelial cells. Fully mature VEGF-C has affinity for VEGFR-2 which is also expressed on lymphatic endothelial cells (LEC) (5). A mutated version of VEGF-C, VEGF-C156S, in which cysteine 156 is replaced by a serine, specifically activates VEGFR-3 but not VEGFR-2 (6). Specific activation of VEGFR-3 by VEGF-C156S is sufficient to induce lymphangiogenesis, as demonstrated in K14-VEGF-C156S mice. Upon stimulation, the receptor dimerizes and is phosphorylated at several tyrosine residues. These phosphorylation sites activate several adaptor molecules along with further downstream mediators including JNK, ERK1/2, PI3K and PKB/AKT, ultimately leading phenotypic changes of LECs. However, the exact transcriptional mediators are not fully investigated yet. These transcription factors might be essential in mediating the effect of VEGF-C and could serve as potential therapeutic targets of the lymphatic endothelium. |
Sample description |
---|
We have used primary lymphatic endothelial cells, which have previously been isolated from human foreskin (7). Cells were cultured on collagen-coated culture dishes in EBM medium (Lonza) supplemented with 20% FBS (Life Technologies), 1x penicillin/streptomycin (Life Technologies), 2mM L-Glutamine (Life Technologies), 25 µg/ml cAMP (Sigma-Aldrich), and 10 µg/ml hydrocortisone (Sigma-Aldrich). For this study, we used cells isolated from 3 individual donors, at low passage numbers (<=6). Cells were seeded at 70% confluency and were starved in EBM + 0.2% BSA over night before stimulation with 1.5 µg/ml recombinant human VEGF-C156S (Kari Alitalo, University of Helsinki, Finland) for 0 min, 15 min, 30 min, 45 min, 60 min, 80 min, 100 min, 2 h, 2.5h, 3 h, 3.5 h, 4 h, 5 h, 6 h, 7 h, or 8 h (16 different time points). The 0 min time point of treatment served as a control for the other time points (Figure 1). |
Quality control |
---|
Marker gene expression |
Profiled time course samples
Only samples that passed quality controls (Arner et al. 2015) are shown here. The entire set of samples are downloadable from FANTOM5 human / mouse samples
12260-130A1 | Lymphatic Endothelial cells response to VEGFC | 00hr00min | biol_rep1 (MM XIX - 1) |
12261-130A2 | Lymphatic Endothelial cells response to VEGFC | 00hr15min | biol_rep1 (MM XIX - 2) |
12262-130A3 | Lymphatic Endothelial cells response to VEGFC | 00hr30min | biol_rep1 (MM XIX - 3) |
12263-130A4 | Lymphatic Endothelial cells response to VEGFC | 00hr45min | biol_rep1 (MM XIX - 4) |
12264-130A5 | Lymphatic Endothelial cells response to VEGFC | 01hr00min | biol_rep1 (MM XIX - 5) |
12265-130A6 | Lymphatic Endothelial cells response to VEGFC | 01hr20min | biol_rep1 (MM XIX - 6) |
12266-130A7 | Lymphatic Endothelial cells response to VEGFC | 01hr40min | biol_rep1 (MM XIX - 7) |
12267-130A8 | Lymphatic Endothelial cells response to VEGFC | 02hr00min | biol_rep1 (MM XIX - 8) |
12268-130A9 | Lymphatic Endothelial cells response to VEGFC | 02hr30min | biol_rep1 (MM XIX - 9) |
12269-130B1 | Lymphatic Endothelial cells response to VEGFC | 03hr00min | biol_rep1 (MM XIX - 10) |
12270-130B2 | Lymphatic Endothelial cells response to VEGFC | 03hr30min | biol_rep1 (MM XIX - 11) |
12271-130B3 | Lymphatic Endothelial cells response to VEGFC | 04hr | biol_rep1 (MM XIX - 12) |
12272-130B4 | Lymphatic Endothelial cells response to VEGFC | 05hr | biol_rep1 (MM XIX - 13) |
12273-130B5 | Lymphatic Endothelial cells response to VEGFC | 06hr | biol_rep1 (MM XIX - 14) |
12274-130B6 | Lymphatic Endothelial cells response to VEGFC | 07hr | biol_rep1 (MM XIX - 15) |
12275-130B7 | Lymphatic Endothelial cells response to VEGFC | 08hr | biol_rep1 (MM XIX - 16) |
12382-131E6 | Lymphatic Endothelial cells response to VEGFC | 00hr00min | biol_rep2 (MM XIV - 1) |
12383-131E7 | Lymphatic Endothelial cells response to VEGFC | 00hr15min | biol_rep2 (MM XIV - 2) |
12384-131E8 | Lymphatic Endothelial cells response to VEGFC | 00hr30min | biol_rep2 (MM XIV - 3) |
12385-131E9 | Lymphatic Endothelial cells response to VEGFC | 00hr45min | biol_rep2 (MM XIV - 4) |
12386-131F1 | Lymphatic Endothelial cells response to VEGFC | 01hr00min | biol_rep2 (MM XIV - 5) |
12387-131F2 | Lymphatic Endothelial cells response to VEGFC | 01hr20min | biol_rep2 (MM XIV - 6) |
12388-131F3 | Lymphatic Endothelial cells response to VEGFC | 01hr40min | biol_rep2 (MM XIV - 7) |
12389-131F4 | Lymphatic Endothelial cells response to VEGFC | 02hr00min | biol_rep2 (MM XIV - 8) |
12390-131F5 | Lymphatic Endothelial cells response to VEGFC | 02hr30min | biol_rep2 (MM XIV - 9) |
12391-131F6 | Lymphatic Endothelial cells response to VEGFC | 03hr00min | biol_rep2 (MM XIV - 10) |
12392-131F7 | Lymphatic Endothelial cells response to VEGFC | 03hr30min | biol_rep2 (MM XIV - 11) |
12393-131F8 | Lymphatic Endothelial cells response to VEGFC | 04hr | biol_rep2 (MM XIV - 12) |
12394-131F9 | Lymphatic Endothelial cells response to VEGFC | 05hr | biol_rep2 (MM XIV - 13) |
12395-131G1 | Lymphatic Endothelial cells response to VEGFC | 06hr | biol_rep2 (MM XIV - 14) |
12396-131G2 | Lymphatic Endothelial cells response to VEGFC | 07hr | biol_rep2 (MM XIV - 15) |
12397-131G3 | Lymphatic Endothelial cells response to VEGFC | 08hr | biol_rep2 (MM XIV - 16) |
12504-133A2 | Lymphatic Endothelial cells response to VEGFC | 00hr00min | biol_rep3 (MM XXII - 1 ) |
12505-133A3 | Lymphatic Endothelial cells response to VEGFC | 00hr15min | biol_rep3 (MM XXII - 2) |
12506-133A4 | Lymphatic Endothelial cells response to VEGFC | 00hr30min | biol_rep3 (MM XXII - 3) |
12507-133A5 | Lymphatic Endothelial cells response to VEGFC | 00hr45min | biol_rep3 (MM XXII - 4) |
12508-133A6 | Lymphatic Endothelial cells response to VEGFC | 01hr00min | biol_rep3 (MM XXII - 5) |
12509-133A7 | Lymphatic Endothelial cells response to VEGFC | 01hr20min | biol_rep3 (MM XXII - 6) |
12510-133A8 | Lymphatic Endothelial cells response to VEGFC | 01hr40min | biol_rep3 (MM XXII - 7) |
12511-133A9 | Lymphatic Endothelial cells response to VEGFC | 02hr00min | biol_rep3 (MM XXII - 8) |
12512-133B1 | Lymphatic Endothelial cells response to VEGFC | 02hr30min | biol_rep3 (MM XXII - 9) |
12513-133B2 | Lymphatic Endothelial cells response to VEGFC | 03hr00min | biol_rep3 (MM XXII - 10) |
12514-133B3 | Lymphatic Endothelial cells response to VEGFC | 03hr30min | biol_rep3 (MM XXII - 11) |
12515-133B4 | Lymphatic Endothelial cells response to VEGFC | 04hr | biol_rep3 (MM XXII - 12) |
12516-133B5 | Lymphatic Endothelial cells response to VEGFC | 05hr | biol_rep3 (MM XXII - 13) |
12517-133B6 | Lymphatic Endothelial cells response to VEGFC | 06hr | biol_rep3 (MM XXII - 14) |
12518-133B7 | Lymphatic Endothelial cells response to VEGFC | 07hr | biol_rep3 (MM XXII - 15) |
12519-133B8 | Lymphatic Endothelial cells response to VEGFC | 08hr | biol_rep3 (MM XXII - 16) |